Scholars Central

Conference abstractPublished 10 Sep 2012

Pro-inflammatory roles of the death receptor-CD95

Authors: Legembre Patrick

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

CD95 (also known as Fas) is a death receptor that belongs to the TNF receptor superfamily and plays a pivotal role in immune surveillance. Upon binding of its cognate ligand CD95L, the intracellular region of CD95 recruits the adaptor protein FADD, which in turn binds caspases -8/-10. This complex called DISC, for Death Inducing Signalling Complex allows caspase clustering, which is instrumental in their activation and the subsequent induction of apoptosis. CD95L is detected mainly at the surface of innate and adaptive immune cells where it contributes to the elimination of infected and transformed cells. We recently found that the amount of CD95L is increased in sera of patients affected by chronic inflammatory disorders as compared to healthy subjects and correlates with disease progression. Although this soluble form of CD95L arises from the cleavage by metalloproteinases of the cytotoxic transmembrane ligand, it fails to kill cells. Instead, it promotes accumulation of activated T-cells in inflamed organs through the induction of a ?non-orthodox? Ca2+/PI3K signaling pathway that relies on the implementation of a new CD95-containing complex that we designated MISC for Motility-Inducing Signalling Complex (Tauzin et al., PLoS Biol, 2011). These findings emphasize that according to its stoichiometry, CD95L does not only behave as a pro-apoptotic cytokine but can also implement non-apoptotic signaling pathways promoting cell migration. These results will open new avenues into the study of the death receptor signaling and provide insight into its role in carcinogenesis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Legembre Patrick”